CA45422-2 - 0x00000000000067A2

Healthy Males & Females

Alchemy

* Stipend may pay up to reflected amount.
Start Date: 
September 29, 2025 - 2:00pm
End Date: 
January 13, 2026 - 7:30am

Study Details

Study Number: CA45422
Group Number: 2
Study Requirement: Healthy Normal Male and Female
Stipend: up to $8,750.00

Study Criteria

Age: 19 - 65
BMI: 18 - 32
Weight Restriction: minimum weight 110 lbs

Study Information

Indication: This investigational medication is being developed to treat ALS (often called Lou Gehrig's disease) which causes muscle weakness and paralysis.
Route of Administration: Injection IV infusion
Blood Draws: 23

Study Schedule

Schedule Type: Short stays with returns
Study Length: 4- Night Stay, 5 Returns & 1 Phone Call

Screening Dates:

Event Day Event Date
Tuesday 9/23/2025
Friday 9/26/2025
Saturday 9/27/2025

Doctor Exam Dates:

Event Day Event Date
Tuesday 9/23/2025
Friday 9/26/2025
Saturday 9/27/2025

Study Dates:

Event Type Start Day Start Date End Day End Date Phase Site
Check-In Monday 9/29/2025 2:00:00 PM Friday 10/3/2025 8:30:00 AM 1 Lincoln
Phone participant Tuesday 10/7/2025 11:30:00 AM 1 Lincoln
Return Tuesday 10/14/2025 7:30:00 AM Tuesday 10/14/2025 8:30:00 AM 1 Lincoln
Return Tuesday 10/28/2025 7:30:00 AM Tuesday 10/28/2025 8:30:00 AM 1 Lincoln
Return Tuesday 11/25/2025 6:30:00 AM Tuesday 11/25/2025 7:30:00 AM 1 Lincoln
Return Tuesday 12/16/2025 6:30:00 AM Tuesday 12/16/2025 7:30:00 AM 1 Lincoln
Return Tuesday 1/13/2026 6:30:00 AM Tuesday 1/13/2026 7:30:00 AM 1 Lincoln